Literature DB >> 21210948

Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use.

Y Ozier1, B J Hunt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21210948     DOI： 10.1111/j.1538-7836.2010.04083.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

1.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

Review 2.  Postpartum hemorrhage: Blood product management and massive transfusion.

Authors:  Benjamin K Kogutt; Arthur J Vaught
Journal:  Semin Perinatol       Date:  2018-11-14       Impact factor: 3.300

Review 3.  Fibrinogen concentrate in bleeding patients.

Authors:  Anne Wikkelsø; Jens Lunde; Mathias Johansen; Jakob Stensballe; Jørn Wetterslev; Ann Merete Møller; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

4.  Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma.

Authors:  Chimdiya Onwukwe; Nuzhat Maisha; Mark Holland; Matt Varley; Rebecca Groynom; DaShawn Hickman; Nishant Uppal; Andrew Shoffstall; Jeffrey Ustin; Erin Lavik
Journal:  Bioconjug Chem       Date:  2018-07-09       Impact factor: 4.774

5.  The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial.

Authors:  Anne Juul Wikkelsoe; Arash Afshari; Jakob Stensballe; Jens Langhoff-Roos; Charlotte Albrechtsen; Kim Ekelund; Gabriele Hanke; Heidi Fosgrau Sharif; Anja U Mitchell; Jens Svare; Ane Troelstrup; Lars Møller Pedersen; Jeannet Lauenborg; Mette Gøttge Madsen; Birgit Bødker; Ann M Møller
Journal:  Trials       Date:  2012-07-17       Impact factor: 2.279

6.  The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.

Authors:  Erhabor Osaro; Adias Teddy Charles
Journal:  J Blood Med       Date:  2011-02-06

Review 7.  Over 50 Years of Fibrinogen Concentrate.

Authors:  Rubens Costa-Filho; Gerald Hochleitner; Michael Wendt; Alexandre Teruya; Donat R Spahn
Journal:  Clin Appl Thromb Hemost       Date:  2015-08-19       Impact factor: 2.389

8.  Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.

Authors:  C Solomon; C Hagl; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2013-02-06       Impact factor: 9.166

Review 9.  Hemostatic agents for prehospital hemorrhage control: a narrative review.

Authors:  Henry T Peng
Journal:  Mil Med Res       Date:  2020-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.